LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Adenosine Injection, USP in 60 mg per 20 mL and 90 mg per 30 mL presentations.

A double injection of intracoronary adenosine improves myocardial reperfusion as well as early clinical outcomes in patients receiving primary percutaneous coronary intervention (PCI) for acute ...

Fresenius Kabi announced the launch of Adenosine Injection, USP, 6mg/2mL and 12mg/4mL, in single-dose Simplist ready-to-administer prefilled syringes. Fresenius Kabi announced the launch of Adenosine ...

April 15, 2008 (Palo Alto, CA and Deerfield, IL) - The US Food and Drug Administration has market-approved regadenoson (Lexiscan), a selective A 2A adenosine-receptor agonist, for resting ...

Adenosine Injection, a pharmacologic stress agent, is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately. Fresenius Kabi announced the ...

SAN FRANCISCO (MarketWatch) -- Teva Pharmaceutical Industries Ltd. said Monday the Food and Drug Administration has granted tentative approval for its Adenosine injection, 3 mg/mL in 20 mL and 30 mL ...

IRVINE, Calif. Teva Health Systems has introduced its adenosine injection, USP in a pre-filled syringe, the company announced Wednesday. Teva’s adenosine is AP rated to Astellas Pharma’s Adenocard IV ...

Nicorandil, a vasodilator, appears to effectively induce hyperemia during fractional flow reserve (FFR) measurement with few adverse events. The drug may prove to be a more convenient, safer ...

Purines are heterocyclic aromatic molecules that are among the oldest and most influential biochemical compounds in evolutionary history. 1 The purine nucleotide adenosine triphosphate (ATP) is the ...